Mallinckrodt Pharmaceuticals (NYSE:MNK) today released results from a clinical pharmacokinetic study evaluating the effect of IV morphine on the absorption of oral acetaminophen, touting the effectiveness of its Ofirmev IV administered acetaminophen over orally administered acetaminophen in adjunct to IV morphine. The results were presented at this year’s Pain Medicine Meeting of the American Society of […]
Neuromodulation/Neurostimulation
PixarBio raises $7m for non-addictive morphine alternative
PixarBio (OTC:PXRB) raised $7 million for its biomaterial-based opioid alternative for post-operative acute and chronic pain relief, about 18% of its $40 million equity financing according to a regulatory filing that the Medford, Mass.-based company filed yesterday. The company’s drug delivery product, NeuroRelease, is an injectable morphine replacement therapy for use in the surgical/hospital setting, the […]
Delivra president & CFO resigns, names new finance VP | Personnel Moves, Nov. 17, 2016
Delivra Corp. (CVE:DVA) said today that its president and CFO, Chris Schnarr, is resigning effective tomorrow and Pascal Attard has been promoted from controller to VP of finance. Attard has worked as controller for Red Tiger Mining Inc. and manager of McGovern, Hurley, Cunningham LLP prior to joining Delivera in 2015. The Toronto-based company said it […]
Touch Surgery, Pacira to develop knee surgery sim
Touch Surgery and Pacira Pharmaceuticals (NSDQ:PCRX) launched the Exparel knee training simulation for the Touch Surgery app, designed to provide clinicians with a virtual training experience for administering the bupivacaine liposome injectable suspension in total knee arthroplasty. The simulation includes a 3D environment where clinical decisions and viewpoints are all dictated by the user and simulates […]
St. Jude wins MRI nod for Proclaim Elite spinal cord stim
St. Jude Medical (NYSE:STJ) said today it won FDA approval for magnetic resonance imaging conditional labeling for its Proclaim Elite spinal cord stimulation system Patients using the company’s Proclaim Elite SCS are now cleared or full-body MRI diagnostics scans, the Little Canada, Minn.-based company said. “This MR Conditional labeling applies to both new patients and those […]
OCUL’s Dextenza meets endpoints in pivotal study
Ocular Therapeutix (NSDQ:OCUL) said today that its post-surgical ocular pain reliever, Dextenza, met both primary endpoints in a pivotal trial for the treatment of post-surgical ocular inflammation and pain. The product is a bioresorbable intracanalicular insert, designed for drug release to the ocular surface for up to 30 days. The randomized, double-masked study enrolled 438 patients who were […]
Paralyzed monkeys walk again with wireless ‘brain-spine interface’
Swiss scientists from the Swiss Federal Institute of Technology helped paralyzed monkeys walk again with a neuroprosthetic interface that acts as a wireless bridge between the brain and the spine, according to a study published today in Nature. Researcher suggested that their method for regaining control of non-functioning limbs could one day lead to paralyzed people being […]
Ex-Cyberonics rep asks appeals court to reinstate whistleblower suit
A former Cyberonics (NSDQ:CYBX) sales rep this week asked the 1st Circuit Court of Appeals to reinstate a File Claims Act suit, claiming his allegations were sufficient to show that the company pressed its reps to offer unnecessary epilepsy implant procedures. The plaintiff, Andrew Hagerty, worked for Cyberonics between 2010 and 2012 and claims that the […]
First patient receives Pixium bionic vision implant
Pixium Vision (EPA:PIX) said today that the 1st patient in the UK was implanted with its IRIS II bionic vision system. The epi-retinal implant has 150 electrodes and a bio-inspired camera intended for patients who have lost sight due to retinitis pigmentosa. The French company said the implantation and activation was performed in September by principal […]
More deaths tied to Medtronic’s SynchroMed II drug pump
The SynchroMed II implantable drug pump was linked to more than 100 adverse events including 2 previously unreported deaths, Medtronic (NYSE:MDT) said last month. In a letter to doctors published yesterday by the U.K.’s Medicines & Healthcare Products Regulatory Agency, Fridley, Minn.-based Medtronic said the SynchroMed II pump can delivery too much medicine but that the exact case of […]
Medtronic warns on deep brain stimulation charger issue
Medtronic (NYSE:MDT) warned customers this month of an issue with some of its Model 37751 rechargers for its deep-brain stimulation devices, saying they may become unresponsive and unable to fully recharge the neurostimulator until they are reset. Customers have complained that some of their rechargers are nonfunctional, bleeping every 5 seconds with a blank display screen, Medtronic warned in […]